Investigating allegations that several drug distributors are buying scarce drugs and reselling them at massive profit to hospitals, a member of the House Oversight and Government Reform Committee has started an investigation. The congressman has requested documentation of what the distributors paid for the drugs and the amounts at which they’re reselling them.
There’s less off the attention-deficit disorder drug Adderall available to the public than there used to be: some even call it a shortage. The company blames the FDA, which has limited the total amount of the drug manufactured: it is, after all, an amphetamine and a controlled substance. Manufacturer Shire has responded to these limits by… hiking the price and making fewer discounts available to consumers.